Ligand Pharmaceuticals Inc (LGND)

113.38 -0.42 (-0.37%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Ligand Pharmaceuticals Cash and Short Term Investments (Quarterly): 219.64M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Cellectar Biosciences Inc 34.26M
Revance Therapeutics Inc 184.08M
Pieris Pharmaceuticals Inc 19.36M
Zymeworks Inc 297.20M
CNS Pharmaceuticals Inc 6.973M